Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1995
12/27/1995EP0688866A1 Thermostable trehalose-releasing enzyme, and its preparation and uses
12/27/1995EP0688565A1 Tablet, capsule, or granule comprising desogestrel
12/27/1995EP0688564A2 Method of controlling release of an active or drug from a silicone rubber matrix
12/27/1995EP0688429A1 Macromolecular microparticles and methods of production
12/27/1995EP0688329A1 Novel phospholipid-saccharide conjugates
12/27/1995EP0688327A1 Analogs for specific oligosaccharide-protein interactions and uses therefor
12/27/1995EP0688229A1 Use of low density lipoprotein with cytotoxic substances
12/27/1995EP0688207A1 Lipid-polymer conjugates and liposomes
12/27/1995EP0688205A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
12/27/1995EP0688166A1 Proteinaceous oil spill dispersant
12/27/1995EP0646002B1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules
12/27/1995EP0578726B1 Virus inactivation method
12/27/1995CN1113955A Medicinal leather and its making method
12/27/1995CN1113698A Amorphophallus rivieri fine flour
12/26/1995US5478829 Solution of sparfloxacin, its preparation and salt of which it is composed
12/26/1995US5478806 Enhancement of antitumor therapy with hemoglobin-based conjugates
12/26/1995US5478805 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
12/26/1995US5478804 Administering cytotoxic conjugates which target tumor cells expressing fibroblast growth factor receptors
12/26/1995US5478593 Applying a polyol syrup such as sorbitol or maltitol followed by application in powder form; carried out without forced drying; chewing gums
12/26/1995US5478578 Micronized active material, excipient mixture with fine and coarse particles
12/26/1995US5478577 Administering controlled release dosage form of opiate analgesics
12/26/1995US5478576 Arabinogalactan derivatives and uses thereof
12/26/1995US5478575 Polymers having benzeneboronic acid groups and insulin complexes of same of a sugar response type
12/26/1995US5478574 Agglomerated hydrophilic complexes with multi-phasic release characteristics
12/26/1995US5478573 Delayed, sustained-release propranolol pharmaceutical preparation
12/26/1995US5478572 Cellulosic polymer matrix and excipients; extended release; side effect reduction; antidepressants and anxiolytic agents
12/26/1995US5478571 Process for the preparation of substantially alcohol free pharmaceutical compositions
12/26/1995US5478569 Cold water dispersible particles of fat-soluble substance encapsulated with protective fish gelatin colloid; nutritional supplements
12/26/1995US5478567 Drug, such as ketoprofen, rosin solubiizer, polymer, softener polyester cloth backing
12/26/1995CA1337797C Medicated cleansing pads
12/26/1995CA1337796C Plasminogen activator-heparin conjugates
12/21/1995WO1995034665A2 Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
12/21/1995WO1995034647A1 Compositions for and methods of enhancing delivery of nucleic acids to cells
12/21/1995WO1995034595A1 Antiviral dendrimers
12/21/1995WO1995034582A1 Bioadhesive starches and process for their preparation
12/21/1995WO1995034533A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
12/21/1995WO1995034528A1 Polyolpolyhydroxystearates
12/21/1995WO1995034328A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes
12/21/1995WO1995034326A1 Pegylation reagents and compounds formed therewith
12/21/1995WO1995034325A1 Delivery of therapeutic agents to receptors using polysaccharides
12/21/1995WO1995034318A1 Solution comprising igf-i or any functional analogue thereof and method for its preparation
12/21/1995WO1995034308A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound
12/21/1995WO1995034302A2 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
12/21/1995WO1995034295A1 A novel method for importing biologically active molecules into cells
12/21/1995WO1995034287A1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
12/21/1995WO1995030423A3 Cancer treatment and metastasis prevention
12/21/1995WO1995024430A3 Block and graft copolymers and methods relating thereto
12/21/1995CA2192541A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes
12/21/1995CA2169747A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
12/20/1995EP0687473A1 Optical isomerization inhibitor
12/20/1995EP0687464A2 Process for manufacturing effervescent tablets and effervescent tablets
12/20/1995EP0687174A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation
12/20/1995EP0687171A1 Use of trans-urocanic acid as an antioxidant and for the prophylaxis and treatment of ageing of the skin
12/20/1995EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds
12/20/1995EP0596049A4 Defoaming composition
12/20/1995EP0576585B1 Viscous surface active composition
12/20/1995EP0553169B1 A method for drug formulation and a pharmaceutical composition
12/20/1995EP0525063B1 Use of specific fatty acids in the manufacture of a medicament for their Iontophoresis delivery
12/20/1995EP0514523B1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated
12/20/1995EP0494996B1 Erodible macroporous hydrogel particles and preparation thereof
12/20/1995EP0180581B2 Drug preparations of reduced toxicity
12/19/1995US5476852 Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
12/19/1995US5476843 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
12/19/1995US5476842 Administering conjugate of cytotoxic phenolic compounds and mono- or disaccharides; damages cancer cells
12/19/1995US5476782 DNA encoding a human 5-HT1E receptor and uses thereof
12/19/1995US5476667 Method for drug formulation and a pharmaceutical composition
12/19/1995US5476666 Glycosaminoglycan-synthetic polymer conjugates
12/19/1995US5476665 Azlactone functional particles incorporated in a membrane formed by solvent phase inversion
12/19/1995US5476659 Killing; particularly lymphocytic leukemia
12/19/1995US5476654 Preparing tablets by mixing terfenadine with a cross-linked sodium carboxymethyl cellulose and a hydrophilic polymer which gels with water
12/19/1995US5476653 Polyoxymethylene-oxyethylene copolymers in conjuction with biomolecules
12/19/1995US5476648 Oil in water emulsions
12/19/1995US5476646 Gastrointestinal tract
12/14/1995WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system
12/14/1995WO1995033773A1 Lysozyme-degradable biomaterials
12/14/1995WO1995033766A1 Branched synthetic peptide conjugate
12/14/1995WO1995033554A1 Use of a polymer material based on modified hydrocolloids as encapsulating material
12/14/1995WO1995033492A1 Methods and compositions for modulation of wound healing
12/14/1995WO1995033491A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995WO1995033490A1 Method of solubilizing substantially water insoluble materials
12/14/1995WO1995033489A1 Stable gel formulation for topical treatment of skin conditions
12/14/1995WO1995033488A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
12/14/1995WO1995033487A1 Injectable formulations containing a desiccant
12/14/1995WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain
12/14/1995WO1995033474A1 Medicinal composition
12/14/1995WO1995033452A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
12/14/1995WO1995033450A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
12/14/1995WO1995033447A1 Stable reverse and multiple fluorocarbon emulsions
12/14/1995DE4420516A1 Polyolpolyhydroxystearate Polyolpolyhydroxystearates
12/14/1995DE4419824A1 Volumen-expandierbares, als Wirkstoffträger insbesondere zur oralen Anwendung geeignete flächige Anwendungsform Volume expandable as drug carriers particularly suitable for oral application area application form
12/14/1995CA2192384A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995CA2192200A1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use
12/14/1995CA2191753A1 Lysozyme-degradable biomaterials
12/14/1995CA2191436A1 Stable reverse and multiple fluorocarbon emulsions
12/14/1995CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system
12/14/1995CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain
12/14/1995CA2190181A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
12/13/1995EP0686399A1 Powdery pharmaceutical preparation and method of manufacturing same
12/13/1995EP0686391A1 Surfactant-free water-in-oil emulsion
12/13/1995EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death